Encompass Health Corporation (EHC)
NYSE: EHC · Services-Hospitals · Birmingham, AL
Our rating: Neutral
Neutral reaffirmed at $137.54, moderate conviction, November 6, 2026.
Breaks if: Two paths move the needle off Neutral. The call turns Positive if revenue growth holds above 12% for two consecutive quarterly prints while FCF yield climbs above 2.0% — together those would signal that the facility pipeline is ramping on schedule and capex intensity is normalizing. The call turns Cautious if CMS proposes an IRF payment-system rate reduction exceeding 2% for FY2027, or if reported revenue growth decelerates below 7% for two consecutive quarters, indicating the volume story is softening faster than the investment cycle assumed.
Key figures
| Market value | $13.1B |
|---|---|
| Revenue, last 12 months | $6.3B |
| Net income, last 12 months | $644M |
| Free cash flow, last 12 months | n/a |
| Price to earnings | 20.4× |
| Free cash flow yield | n/a |
| Dividend yield | 0.6% |
| Operating margin | n/a |
| Return on equity | 25.5% |
| Beta to the S&P 500 | 0.34 |
| Volatility, annualized | 27.5% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| September 30, 2026 | $1.6B | 8.9% | $1.50 | n/a |
| June 30, 2026 | $1.6B | 9.6% | $1.54 | n/a |
| March 31, 2026 | $1.6B | 9.0% | $1.93 | n/a |
| December 31, 2025 | $1.5B | 9.9% | $1.43 | n/a |
| September 30, 2025 | $1.5B | 9.4% | $1.24 | n/a |
| June 30, 2025 | $1.5B | 12.0% | $1.39 | n/a |
| March 31, 2025 | $1.5B | 10.6% | $1.48 | n/a |
| December 31, 2024 | $1.4B | 12.7% | $1.18 | n/a |
Three-model forecasts for the next quarter
Written November 21, 2026, before the report. Each settles from the SEC filing.
- Revenue for the quarter is at least $1.69B: Claude 72%, Gemini 90%, Mistral 42%
- Diluted earnings per share are at least $1.43: Claude 62%, Gemini 95%, Mistral 78%
17 ledger entries and 33 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.